HCV infection clearance with functional or non-functional caspase-12 [1]

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 3, 2007, Pages 416-417

  O'Brien, Thomas R ^a   Kachapati, Kritika ^a   Zhang, Mingdong ^a   Bergeron, Julie ^b   Edlin, Brian R ^c,d   Dean, Michael ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 12;

AFRICAN AMERICAN; CONTROLLED STUDY; DRUG ABUSE; ENZYME ACTIVITY; GENETIC SCREENING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; CASE-CONTROL STUDIES; CASPASE 12; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; LOGISTIC MODELS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SAN FRANCISCO; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33847200376     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520601076074     Document Type: Letter

References (4)

1. Volkmann X, Cornberg M, Wedemeyer H, Lehner F, Manns MP, Schulze-Osthoff K, et al. Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection. Hepatology 2006;43:1311-6.
2. Scott AM, Saleh M. The inflammatory caspases: guardians against infections and sepsis. Cell Death Differ 2006; Epub ahead of print.
3. Kachapati K, O'Brien TR, Bergeron J, Zhang M, Dean M. Population distribution of the functional caspase-12 allele. Hum Mutat 2006;27:975.
4. Atkinson J, Edlin BR, Engels EA, Kral AH, Seal K, Gamache CJ, et al. Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco. J Infect Dis 2003;187:974-81.